Clinical Trial Update: A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety and pharmacokinetics of a single dose of VH3810109 (GSK3810109) given either subcutaneously with rHuPH20 or intravenously, in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH3810109 (VH3810109)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19